Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;11(2):183-92.
doi: 10.2450/2012.0148-12. Epub 2012 Dec 13.

Is self-sufficiency in haemotherapies a practical or necessary goal?

Albert Farrugia  1 , Josephine Cassar
Affiliations
Review

Is self-sufficiency in haemotherapies a practical or necessary goal?

Albert Farrugia et al. Blood Transfus. 2013 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
IG use in the USA and Australia, 2009–2010, reimbursed by public payers. The top indications are shown,. CIPD: chronic inflammatory demyelinating polyradiculopathy; GBS: Guillain-Barré syndrome; MMN: multifocal motor neuropathy; CLL: chronic lymphocytic leukaemia; ITP: idiopathic thrombocytopenic purpura.
Figure 2
Figure 2
Model for estimated latent therapeutic demand (LTD) for IG use in common variable immune deficiency (CVID). A model drawing on the methodology described by Stonebraker et al. was constructed using peer-reviewed literature for the inputs shown in A. The model estimated the importance of each input in the tornado diagram shown in B and estimated a distribution for the usage of IG in CVID (C). The estimated mean usage was 44 g per 1,000 population.
See this image and copyright information in PMC

References

    1. WHO Expert Group. Expert Consensus Statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD) Vox Sang. 2012;103:337–42. - PubMed
    1. Royal Commission of Inquiry on the Blood System in Canada. [Accessed on 02/07/2012];Final Report. 1996 1:63–4. Available at: http://epe.lac-bac.gc.ca/100/200/301/hcan-scan/commission_blood_final_re....
    1. Royal Commission of Inquiry on the Blood System in Canada. [Accessed on 02/07/2012];Final Report. 1996 3:1048. Available at: http://epe.lac-bac.gc.ca/100/200/301/hcan-scan/commission_blood_final_re....
    1. Rickard KA, Batey RG, Dority P, et al. Hepatitis and haemophilia therapy in Australia. Lancet. 1982;2:146–8. - PubMed
    1. de Montalembert M, Costagliola DG, Lefrère JJ, et al. Prevalence of markers for human immunodeficiency virus types 1 and 2, human T-lymphotropic virus type I, cytomegalovirus, and hepatitis B and C virus in multiply transfused thalassemia patients. The French Study Group On Thalassaemia. Transfusion. 1992;32:509–12. - PubMed